PROCEPT BioRobotics Corp.(NASDAQ : PRCT)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Medical Specialties
|TMO||Thermo Fisher Scientific, Inc.||2.46%||606.65||1.0%||$766.54m|
|ISRG||Intuitive Surgical, Inc.||1.18%||340.27||0.8%||$386.56m|
|ALGN||Align Technology, Inc.||2.15%||607.06||6.3%||$332.25m|
|BDX||Becton, Dickinson & Co.||1.92%||247.39||1.0%||$316.50m|
|EW||Edwards Lifesciences Corp.||0.64%||115.74||0.4%||$261.28m|
|BSX||Boston Scientific Corp.||0.53%||44.37||1.0%||$257.07m|
|IDXX||IDEXX Laboratories, Inc.||0.57%||644.63||3.8%||$245.39m|
|A||Agilent Technologies, Inc.||1.55%||158.03||1.6%||$219.68m|
|BAX||Baxter International, Inc.||1.88%||81.18||1.8%||$193.42m|
PROCEPT BioRobotics Corp. is a commercial-stage surgical robotics company, which is focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System, an advanced, image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating BPH. The firm's proprietary AquaBeam Robotic System employs a single-use disposable handpiece to deliver its Aquablation therapy, which combines real-time, multidimensional imaging, personalized treatment planning, automated robotics and heat-free waterjet ablation for targeted and rapid removal of prostate tissue. The company was founded by Nikolai Aljuri and Rodney C. Perkins in 2007 and is headquartered in Redwood City, CA.